Group 1: Company Overview - Company Name: Shandong Boyuan Pharmaceutical Chemical Co., Ltd. [1] - Stock Code: 301617 [1] - Stock Abbreviation: Boyuan Shares [1] Group 2: Investor Relations Activity - Activity Type: Online collective reception day for listed companies in Shandong [2] - Date of Activity: May 15, 2025 [2] - Time of Activity: 15:00 - 16:30 [2] - Location: P5W Investor Relations Interactive Platform [2] Group 3: Key Personnel - Chairman: Li Chenglin [2] - Vice Chairman and General Manager: Yu Guoqing [2] - Vice General Manager and Board Secretary: Zhang Shanggang [2] - Chief Financial Officer: Sun Teng [2] Group 4: Financial Performance - 2024 Revenue: 132,787.79 million yuan, a year-on-year increase of 29.53% [2] - 2024 Net Profit: 21,312.58 million yuan, a year-on-year increase of 17.04% [2] Group 5: Investor Inquiries - Inquiry about overall performance in 2024 compared to 2023 [2] - Company response regarding performance changes [2]
博苑股份(301617) - 2025年5月15日投资者关系活动记录表